DMCC Speciality Chemicals Limited has scheduled a meeting of the Board of Directors for Friday, October 30, 2026. The primary agenda of the meeting is to consider, approve, and take on record the Unaudited (Standalone & Consolidated) Financial Results of the Company for the quarter and half year ended September 30, 2026. The Board will also review the Limited Review Reports on these financial results issued by the Statutory Auditors of the Company.
Pursuant to the company's previous communication dated September 24, 2026, and in accordance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and the Company's internal Code of Conduct for Prevention of Insider Trading, the Trading Window for dealing in securities of the Company will remain closed until 48 hours after the outcome of the Board Meeting. The closure period extends until November 1, 2026, with the Trading Window scheduled to re-open on November 2, 2026.
The disclosure is made pursuant to Regulation 29 and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The communication is signed by Pallavi Pednekar, Company Secretary & Compliance Officer (ICSI Membership No. ACS 33498).